Unrated severityNVD Advisory· Published May 19, 2021· Updated Aug 5, 2024
CVE-2017-17678
CVE-2017-17678
Description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
AI Insight
LLM-synthesized narrative grounded in this CVE's description and references.
Affected products
2- BMC/BMC Remedy Mid Tierdescription
- Range: = 9.1SP3
Patches
Vulnerability mechanics
References
4- bmc.commitrex_refsource_MISC
- remedy.commitrex_refsource_MISC
- docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.htmlmitrex_refsource_MISC
- seclists.org/fulldisclosure/2017/Oct/52mitrex_refsource_MISC
News mentions
0No linked articles in our index yet.